Early discontinuation of PD-1 blockade upon achieving a complete or partial response in patients with advanced melanoma: the multicentre prospective Safe Stop trial.
BMC Cancer
; 21(1): 323, 2021 Mar 25.
Article
in En
| MEDLINE
| ID: mdl-33765967
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Skin Neoplasms
/
Withholding Treatment
/
Programmed Cell Death 1 Receptor
/
Immune Checkpoint Inhibitors
/
Melanoma
Type of study:
Clinical_trials
/
Guideline
/
Observational_studies
/
Prognostic_studies
/
Qualitative_research
Limits:
Adult
/
Female
/
Humans
/
Male
Language:
En
Journal:
BMC Cancer
Journal subject:
NEOPLASIAS
Year:
2021
Type:
Article
Affiliation country:
Netherlands